Skip to content
Phone: +44 141 899 0081 Email: info@kinesysconsulting.com
  • Twitter
  • Linkedin

Kinesys Consulting

  • Home
  • Our Team
    • Directors & Senior Consultants
    • Board of Medical, Scientific & Business Advisors
  • Regulatory Services
    • Scientific Advice
    • Paediatric Investigation Plan
    • Orphan Drug
    • PRIME & PIM Schemes
    • Clinical Trial Authorisation
    • Marketing Authorisation Application
    • Oral Explanation
  • Strategic Services
    • Regulatory & Development Roadmap
    • Expedited Pathways
    • Due Diligence
    • Advanced Therapies
    • Biotechnology
  • Writing Services
    • Regulatory Writing
    • Marketing Authorisation
    • Product Information
    • Medical & Clinical Writing
    • Scientific Communications
  • Medical Devices
    • Regulatory Consultancy
    • Drug-Device Combinations (DDC)
    • CE Marking
    • UKCA Marking
    • UK Responsible Person Service
    • Internal and Supplier Audits
    • ISO 13485 Support
  • News
  • Join Us
  • Contact

NICE-MHRA2

Home / NICE-MHRA2

NICE-MHRA2

By sonia ziouani ammor
Written By sonia ziouani ammor

Post navigation

Kinesys Consulting secures its first PIM designation from UK MHRA under the EAMS – Early Access to Medicines Scheme

Categories

Recent Posts

  • Kinesys Medical Writing
  • 30 minutes of complimentary consultation with our regulatory affairs experts
  • Medical Device Training Courses
  • 10 minutes of FREE consultation with our Medical Device experts. Book your place now!
  • Soligenix,Inc granted an ILAP ‘Innovation Passport’

Tweets

For More Updates Follow Us

LinkedIn
Twitter
Visit Us
Follow Me
Copyright Kinesys Consulting